Thus, targeting insulin for brain health may have clinical implications since nearly 5 million Americans are living with Alzheimer's disease and almost 90 million have prediabetes (Matthews et al., 2019). The gene discussed is INS; the disease is early-onset autosomal dominant Alzheimer disease.